New lung cancer Drug's Real-World safety under the microscope in china
NCT ID NCT07143513
Summary
This study aims to understand the safety and side effects of the drug sotorasib when used in real-world medical settings in China. It will follow about 115 Chinese adults with a specific type of advanced lung cancer who have already tried at least one other treatment. The main goal is to track any health problems that occur while taking the drug and see how long patients live.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Boao Evergrande International Hospital
RECRUITINGQionghai, Hainan, 571400, China
-
Boao Super Hospital
RECRUITINGQionghai, Hainan, 571499, China
-
Ruijin-Hainan Hospital Shanghai Jiao Tong University School of Medicine Hainan Boao Research Hospital
RECRUITINGQionghai, Hainan, 57400, China
Conditions
Explore the condition pages connected to this study.